Opendata, web and dolomites

APT SIGNED

The Sound of a Healthy Herd. Revolutionising the Care of Dairy Cattle with Pioneering Acoustic Technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "APT" data sheet

The following table provides information about the project.

Coordinator
ARMENTA LTD 

Organization address
address: 5 HASHARON ST.
city: KFAR SAVA
postcode: 4427120
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 3˙207˙685 €
 EC max contribution 2˙245˙379 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-SMEInst-2018-2020-3
 Funding Scheme SME-2b
 Starting year 2020
 Duration (year-month-day) from 2020-04-01   to  2022-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ARMENTA LTD IL (KFAR SAVA) coordinator 2˙245˙379.00

Map

 Project objective

'Armenta Ltd, was established to address the most-costly disease affecting dairy farming today: Bovine Mastitis. Mastitis is the most pressing disease affecting cows, however antibiotics are the only available option worldwide - close to 50% of antibiotics are used in food producing animals. The continued use of antibiotics in the treatment and prevention of infections of dairy cows has a direct effect on fostering Anti-Microbial Resistance (AMR), an urgent matter of particular public interest. The continued use of antibiotics also weakens the cow’s health, decreasing its milk production and eventually, weak cows are removed from the herd, causing high economic losses that can reach €2.4B per year in Europe alone. Armenta was therefore established to address these pressing economic effects, with a revolutionary way of using APT. Armenta developed innovative non-invasive; antibiotics free therapies based on acoustic pulse technology (APT). APT has been used for over 20 years in human healthcare treating inflammatory diseases. Armenta employs experts in acoustic pulse treatment and engineering, mastitis researchers, ex-dairy farmers and dairy farming operation, bringing their skills and proficiency into developing the optimal solutions for bovine mastitis. Armenta aims at becoming a leader in 1) fighting the spread of AMR 2) boosting the dairy economy giving €1.4B cash back to the EU farmers each year 3) increasing cow’s welfare and longevity. Moreover, it aims at being considered the #1 alternative to antibiotics, endorsed by leading international organization. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "APT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "APT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MCBD (2019)

MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINE

Read More  

INDEXAR (2020)

DEVELOPING A SCALABLE MOBILE AR BROWSER

Read More  

SQP (2019)

Opening new markets for Single Quantum Photodetectors

Read More